Loading
A phase 1/2 trial of bevacizumab, oxaliplatin and capecitabine in colorectal cancer, run by Nanjing Leads Biolabs Co.,Ltd, not yet recruiting.
A Clinical Trial of LBL-024 Combination Drug in Patients With Metastatic Colorectal Carcinoma is a phase 1/2, randomised interventional study registered as NCT07791758 by Nanjing Leads Biolabs Co.,Ltd, with a registry enrolment figure of 369 participants, started 2026-09-04 and due to reach its primary completion in 2030-09-04. Interventions recorded: LBL-024 for Injection; Bevacizumab injection; Oxaliplatin injection; Capecitabine tablets; Fruquintinib Capsules. Conditions listed: Metastatic Colorectal Carcinoma. Primary outcome: Objective Response Rate (ORR); Occurrence of adverse event (AE) and serious adverse event (SAE). Sites: China. No results are recorded here; the registry entry is the source.
Shares Anti-angiogenic therapy, Bevacizumab, Capecitabine, Monoclonal antibodies and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Platinum agents, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Capecitabine, Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Anti-angiogenic therapy, Bevacizumab, Monoclonal antibodies, Colon cancer (adenocarcinoma of the colon) and the tag colorectal-deep-dive.